Modern Healthcare Technology Holdings Limited (Stock Code: 919) reported interim results for the six months ended 30 September 2025. The unaudited consolidated revenue was HK$222.67 million, a slight decrease from HK$224.25 million in the same period last year. The Group turned from a loss of HK$16.13 million in 2024 to a profit of HK$6.95 million this period, with basic earnings per share at HK0.72 cents (2024: loss per share of HK1.80 cents).

During the period, 91.0% of revenue (HK$202.67 million) was generated from beauty and wellness services—including beauty and facial, slimming, and spa—while sales of skincare and wellness products contributed the remaining 9.0%, or HK$20.01 million. The Group operated 29 service centers in Hong Kong with a total gross floor area of approximately 153,970 square feet and 8 centers in Singapore. Employee benefit expenses totaled HK$131.33 million, reflecting an 11.3% decrease compared with the prior year.

At period-end, cash, bank balances, and fixed deposits reached HK$248.51 million, while bank borrowings stood at HK$53,000. Capital expenditures (excluding additions to right-of-use assets) were HK$2.11 million, mostly for leasehold improvements and equipment. No interim dividend was proposed.

Management noted that Hong Kong’s economy showed signs of recovery, benefiting from steady domestic consumption. In Singapore, the Group’s operations encompassed 8 service centers and recorded segment revenue of HK$23.52 million. The Directors remain focused on maintaining service quality through staff training and prudent cost management. The announcement also highlighted ongoing measures designed to reinforce corporate governance and risk controls, consistent with relevant listing requirements.